[1]Jemal A, Tiwari RC, Murray T, et al.Cancer statistics,2004[J].CA Cancer J Clin,2004,54(1):8-29.[2]Hecht SS.Tobacco carcinogens, their biomarkers and tobacco-induced cancer[J].Nat Rev Cancer,2003,3(10):733-744.[3]D'Souza G, Kreimer AR, Viscidi R, et al.Case-control study of human papillomavirus and oropharyngeal cancer[J].N Engl J Med,2007,356(19):1944-1956.[4]Ambros V.The functions of animal microRNAs[J].Nature,2004,431(7006):350-355.[5]Xu Y, Liu L, Liu J, et al.A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma[J].Int J Cancer,2011,128(2):412-417.[6]Hu Z, Chen J, Tian T, et al.Genetic variants of miRNA sequences and non-small cell lung cancer survival[J].J Clin Invest,2008,118(7):2600-2608.[7]Yu CC, Chen YW, Chiou GY,et al.MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation[J].Oral Oncol,2011,47(3):202-210.[8]Takamizawa J, Konishi H, Yanagisawa K, et al.Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival[J].Cancer Res,2004,64(11):3753-3756.[9]Wang S, Tang Y, Cui H, et al.Let-7/miR-98 regulate Fas and Fas-mediated apoptosis[J].Genes Immun,2011,12(2):149-154.[10]Calin GA, Sevignani C, Dumitru CD, et al.Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J].Proc Natl Acad Sci U S A,2004,101(9):2999-3004.[11]Mayr C, Hemann MT, Bartel DP.Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation[J].Science,2007,315(5818):1576-1579.[12]Yang J, Zhou F, Xu T, et al.Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas[J].Mutat Res,2008,638(1-2):205-209.[13]Chang CJ, Hsu CC, Chang CH, et al.Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer[J].Oncol Rep,2011,26(4):1003-1010. |